CVS Health Corporation (CVS) — Stock Price, Chart & Analysis
CVS Health Corporation (CVS) is a Healthcare stock currently trading at $100, up 0.00% on the day. It carries a market capitalization of $122.40B and a trailing P/E ratio of 25.38. Over the past 52 weeks, CVS has traded between $64.32 and $110.68. CVS Health Corporation pays a dividend yielding 2.8%. View the live CVS chart, technical opinion, analyst ratings, fundamentals and latest news below.
CVS Health Corporation (CVS) key data
| Price | $100 |
| Change (today) | +0.00% |
| Previous close | $100 |
| Market cap | $122.40B |
| P/E ratio (TTM) | 25.38 |
| EPS (TTM) | $3.77 |
| Dividend yield | 2.8% |
| 52-week high | $110.68 |
| 52-week low | $64.32 |
| Beta | 0.60 |
| Avg. volume | 8.42M |
| Sector | Healthcare |
| Industry | Healthcare Plans |
Frequently asked questions about CVS Health Corporation (CVS)
How much does one share of CVS Health Corporation cost?
As of the latest update, one share of CVS Health Corporation (CVS) trades at $100 (+0.00% today).
What is CVS Health Corporation's market cap?
CVS Health Corporation has a market capitalization of approximately $122.40B.
What is CVS Health Corporation's P/E ratio?
CVS Health Corporation has a trailing price-to-earnings (P/E) ratio of 25.38.
What is CVS Health Corporation's earnings per share (EPS)?
CVS Health Corporation's trailing twelve-month EPS is $3.77.
Does CVS Health Corporation pay a dividend?
Yes — CVS Health Corporation pays a dividend with a yield of 2.8% ($2.66 per share annually).
What is CVS Health Corporation's 52-week trading range?
Over the past year, CVS has traded between $64.32 and $110.68.
What is the analyst price target for CVS Health Corporation?
The mean analyst price target for CVS Health Corporation is $115.64. This is informational only and not investment advice.
Latest CVS Health Corporation (CVS) news
- Healthcare giant slashes key consultation fee to beat rivalsNews · Aug 8, 2026
- UNH Leads Its Peer Group. You Pay For ThatNews · Aug 7, 2026
- CVS Health (CVS) Is Down 8.6% After Raising 2026 Guidance And Expanding GLP-1 Tie-Up With Lilly – Has The Bull Case Changed?News · Aug 7, 2026
- CVS Health (CVS) Stock Gets Fair Value Bump As Analysts Turn More ConstructiveNews · Aug 6, 2026
- Oscar Health Stock Falls After Earnings Beat and Guidance HikeNews · Aug 6, 2026
- Environmental Health Risks Are Rising This Summer - Here's How CVS Health Is Helping People Stay ProtectedNews · Aug 6, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live CVS dashboard…